Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Journal of Clinical Medicine
|
January 8, 2025
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams
Patrick A Cosgrove, Andrea H Bild, Thanh H Dellinger, et al.
Oncotarget
|
February 1, 2018
Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile
Fan Wang, Jeremy T-H Chang, Zhenyu Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind
Rena Emond, Jeffrey West, Vince Grolmusz, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Long Non-Coding RNA <i>ANRIL</i> as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma
Adam M Lee, Asmaa Ferdjallah, Elise Moore, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
December 5, 2024
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview
Pankaj Garg, Gargi Singhal, Siddhika Pareek, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2019
Discovering long noncoding RNA predictors of anticancer drug sensitivity beyond protein-coding genes
Aritro Nath, Eunice Y T Lau, Adam M Lee, et al.
Elife
|
September 29, 2023
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
Elena Farmaki, Aritro Nath, Rena Emond, et al.
Molecular Systems Biology
|
March 27, 2026
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind
Rena Emond, Jeffrey West, Vince K Grolmusz, et al.
Cancer Cell International
|
June 23, 2020
Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model
Vince Kornél Grolmusz, Jinfeng Chen, Rena Emond, et al.
Genome Research
|
August 30, 2017
Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies
Paul Geeleher, Zhenyu Zhang, Fan Wang, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Journal of Clinical Medicine
|
January 8, 2025
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams
Patrick A Cosgrove, Andrea H Bild, Thanh H Dellinger, et al.
Oncotarget
|
February 1, 2018
Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile
Fan Wang, Jeremy T-H Chang, Zhenyu Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind
Rena Emond, Jeffrey West, Vince Grolmusz, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Long Non-Coding RNA <i>ANRIL</i> as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma
Adam M Lee, Asmaa Ferdjallah, Elise Moore, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
December 5, 2024
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview
Pankaj Garg, Gargi Singhal, Siddhika Pareek, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2019
Discovering long noncoding RNA predictors of anticancer drug sensitivity beyond protein-coding genes
Aritro Nath, Eunice Y T Lau, Adam M Lee, et al.
Elife
|
September 29, 2023
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
Elena Farmaki, Aritro Nath, Rena Emond, et al.
Molecular Systems Biology
|
March 27, 2026
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind
Rena Emond, Jeffrey West, Vince K Grolmusz, et al.
Cancer Cell International
|
June 23, 2020
Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model
Vince Kornél Grolmusz, Jinfeng Chen, Rena Emond, et al.
Genome Research
|
August 30, 2017
Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies
Paul Geeleher, Zhenyu Zhang, Fan Wang, et al.
Page
of 5